MedPath

A trial to test the safety of a herbal formulatio

Phase 1
Completed
Registration Number
CTRI/2018/02/011689
Lead Sponsor
SK Biolabs
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
100
Inclusion Criteria

Healthy Human volunteers

Exclusion Criteria

Patients suffering from any disease.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Any toxic side effects after application of SKBBRHM on skin such as irritation, redness, inflammation, itching, fever, nausea, vomiting, shivering, cough, faintness etc.Timepoint: 30.00 Minutes
Secondary Outcome Measures
NameTimeMethod
Any toxic side effects after application of SKBBRHM on skin such as irritation, redness, inflammation, itching, fever, nausea, vomiting, shivering, cough, faintness etc.Timepoint: 30.0 Days
© Copyright 2025. All Rights Reserved by MedPath